[Federal Register: July 23, 2003 (Volume 68, Number 141)]
[Notices]               
[Page 43534]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23jy03-62]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Drug Safety and Risk Management Advisory Committee; Amendment of 
Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Drug Safety and Risk Management 
Advisory Committee. This meeting was announced in the Federal Register 
of June 30, 2003 (68 FR 38713). The amendment is being made to reflect 
a change in the Location portion of the document. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT:  Kimberly Littleton Topper, Center for 
Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12535. Please call the Information Line for up-to-date 
information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 30, 2003, 
FDA announced that a meeting of the Drug Safety and Risk Management 
Advisory Committee would be held on September 18, 2003. On page 38714, 
in the first column, the Location portion of the meeting is amended to 
read as follows:
    Location: Holiday Inn, the Ballroom, 8777 Georgia Ave., Silver 
Spring, MD.
    This notice is given under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: July 17, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-18633 Filed 7-22-03; 8:45 am]

BILLING CODE 4160-01-S